Vanzacaftor is a small-molecule compound designed to correct the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. It is used in combination with other CFTR modulators to enhance CFTR quantity and activity at the cell surface.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vanzacaftor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Bexotegras
pharmaceutical raw material
Probenecid sodium
pharmaceutical raw material
Retatrutide
pharmaceutical raw material
Ambroxol hydrochloride
pharmaceutical raw material
The international HS code for Vanzacaftor (CAS 2374124-49-7) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(14S)-8-[3-(2-dispiro[2.0.24.13]heptan-7-ylethoxy)pyrazol-1-yl]-12,12-dimethyl-2,2-dioxo-2lambda6-thia-3,9,11,18,23-pentazatetracyclo[17.3.1.111,14.05,10]tetracosa-1(22),5(10),6,8,19(23),20-hexaen-4-one
VCSUIBJKYCVWNF-NRFANRHFSA-N
CC1(C[C@@H]2CCCNC3=NC(=CC=C3)S(=O)(=O)NC(=O)C4=C(N1C2)N=C(C=C4)N5C=CC(=N5)OCCC6C7(C68CC8)CC7)C
Sourcing Vanzacaftor?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.